Tg Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
TGTX chart
What traders are saying about $TGTX
Latest postsTg Therapeutics, Inc. news
- Why TG Therapeutics (TGTX) Shares Climbed After Its Latest Update
Yahoo Finance ·
- TG Therapeutics (TGTX) Stock May Be Underpriced Relative To Earnings
Yahoo Finance ·
- Form SCHEDULE 13G/A TG THERAPEUTICS, INC. Filed by: BlackRock, Inc.
StreetInsider ·
- BlackRock reports a passive stake in TG Therapeutics (TGTX), with one ETF's interest exceeding 5%.
Stock Titan ·
- How Investors Are Reacting To TG Therapeutics (TGTX) Early MS Cell Therapy Data
Yahoo Finance ·
- HCA Healthcare Q3 Earnings Beat Estimates on Higher Admissions
Yahoo Finance ·
- TG Therapeutics: The Business Is More Attractive Than The Valuation (NASDAQ:TGTX)
Seeking Alpha ·
- Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Yahoo Finance ·
- Henry Schein to Report Q3 Earnings: Here's What You Should Know
Yahoo Finance ·
- TNGX Stock Falls 16% Despite Positive Pancreatic Cancer Study Data
Yahoo Finance ·
- Incyte & Genmab Collaborate to Develop a New Colorectal Cancer Therapy
Yahoo Finance ·
- RDY Q2 Earnings & Revenues Miss Estimates as Lenalidomide Sales Fall
Yahoo Finance ·
Tg Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $616.3M | $329.0M | $233.7M | $2.8M |
| Net income | $447.2M | $23.4M | $12.7M | -$198.3M |
| Diluted EPS | $2.77 | $0.15 | $0.09 | $-1.65 |
| Total assets (year end) | $1.06B | $577.7M | $329.6M | $193.6M |
| Cash and equivalents (year end) | $79.1M | $179.9M | $92.9M | $102.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Tg Therapeutics, Inc.
- Ticker
- TGTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1001316
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
Frequently asked questions
What exchange is Tg Therapeutics, Inc. listed on?
Tg Therapeutics, Inc. trades on the Nasdaq under the ticker symbol TGTX.
What industry is Tg Therapeutics, Inc. in?
Tg Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Tg Therapeutics, Inc. headquartered?
Tg Therapeutics, Inc.'s business address on file with the SEC is in New York, NY.
When does Tg Therapeutics, Inc.'s fiscal year end?
Tg Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Tg Therapeutics, Inc. report?
Tg Therapeutics, Inc. reported $616.3M in revenue for calendar year 2025, according to its SEC filings.